Arena Pharmaceuticals has rehired Robert Hoffman as vice president (VP), finance and chief financial officer (CFO), effective 29 August 2011. Hoffman served in various financial positions with Arena for over 13 years before departing in March to work for a private biopharmaceutical company.
Hoffman currently serves as a member of the Financial Accounting Standards Board’s (FASB) small business advisory committee and the steering committee of the Association of Bioscience Financial Officers (ABFO). He is also a member and a former director and president of the San Diego Chapter of Financial Executives International.
Hoffman previously served as Arena’s VP, finance and CFO from December 2005 to March 2011.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.